Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 42 Rectal Neoplasms 31 Colorectal Neoplasms 31 Pancreatic Neoplasms 30 Neoplasms 26 Stomach Neoplasms 20 Neoplasm Metastasis 17 Colonic Neoplasms 13 Unspecified Adult Solid Tumor, Protocol Specific 12 Esophageal Neoplasms 12 Carcinoma, Non-Small-Cell Lung 11 Solid Tumor 7 Biliary Tract Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 4 Ovarian Neoplasms 4 Liver Neoplasms 4 Carcinoma, Hepatocellular 4 Bile Duct Neoplasms 4 Triple Negative Breast Neoplasms 3 Prostatic Neoplasms 3 Melanoma 3 Head and Neck Neoplasms 3 Gallbladder Neoplasms 3 Carcinoma, Renal Cell 3 Carcinoma, Ovarian Epithelial 3 Appendiceal Neoplasms 3 Anus Neoplasms 3 Adenocarcinoma 3 Vaginal Neoplasms 2 Uterine Cervical Neoplasms 2

Interventions

Oxaliplatin 1 Folfox protocol 1 Capecitabine 1 ASTX-660 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Locally-advanced Rectal Cancer × Capecitabine × Clear all

NCT05912075 2024-02-08

PRAAR1

Gustave Roussy, Cancer Campus, Grand Paris

Phase 1 Recruiting

Gastrointestinal

Locally-advanced Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡